maxacalcitol

DRUG3 trials

Sponsors

Abbott, AbbVie (prior sponsor, Abbott)

Conditions

Chronic Kidney Disease on HemodialysisHemodialysisSecondary Hyperparathyroidism

Phase 2

Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis

CompletedNCT00667576

AbbottChronic Kidney Disease on Hemodialysis, Secondary Hyperparathyroidism

Start: 2008-04-30End: 2009-03-31Updated: 2012-01-20

Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism

CompletedNCT00990704

AbbottHemodialysis, Secondary Hyperparathyroidism

Start: 2009-10-31End: 2010-05-31Updated: 2011-07-11

Phase 3

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

CompletedNCT01341782

AbbVie (prior sponsor, Abbott)Hemodialysis, Secondary Hyperparathyroidism

Start: 2011-05-31End: 2012-04-30Updated: 2013-06-06